| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Quiq, Inc. is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RiverMend Health is a premier provider of scientifically driven, specialty behavioral health services to those suffering from alcohol and drug dependency, dual disorders, eating disorders, obesity and chronic pain.
Leader Health and Fitness is a York, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Grant Regional Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Grant Regional Health Center is based in Lancaster, WI. You can find more information on Grant Regional Health Center at www.grantregional.com